2010 Sponsors

Gold Sponsors

BAKER & MCKENZIE

Baker & McKenzie Amsterdam is a leading Dutch law firm focusing on providing innovative legal services to clients in the business community. Baker & McKenzie Amsterdam has over 60 years of experience in international and national legal advice.

We represent Venture Capital & Private Equity Investors in a broad variety of industries, with extensive experience and a proven track record in Biotech and pharmaceuticals. We are able to efficiently deliver the specialized knowledge crucial to evaluating, structuring, consuming and exiting investments of all kinds.

Baker & McKenzie also represenets investee cvompanies within and across all domestic and global markets. We work with entrepreneurs and established management teams to structure and form entities of all kinds, assist with the negotiation and consumption of equity and debt financing crucial to the success of every enterprise.

Please contact Edwin Liem for more information:
Edwin Liem
Partner, Corporate M&A, PE & VC
+31 20 551 7514
Edwin.liem@bakermckenzie.com

Baker & McKenzie Amsterdam N.V.
Claude Debussylaan 54
P.O. Box 2720, 1000 CS
AMSTERDAM, the Netherlands

Tel:    +31 20 551 7555
Fax:    +31 20 626 7949

www.bakermckenzie.com/amsterdam

info@amsterdam@bakermckenzie.com           

PricewaterhouseCoopers

PricewaterhouseCoopers (www.pwc.com) provides industry-focused assurance, tax and advisory services to build public trust and enhance value for our clients and their stakeholders.  More than 163,000 people in 151 countries across our network share their thinking, experience and solutions to develop fresh perspectives and practical advice.

NYSE Euronext

NYSE Euronext (NYX) is a leading global operator of financial markets and provider of innovative trading technologies. The company's exchanges in Europe and the United States trade equities, futures, options, fixed-income and exchange-traded products. With more than 8,000 listed issues, NYSE Euronext's equities markets – the New York Stock Exchange, NYSE Euronext, NYSE Amex, NYSE Alternext and NYSE Arca – represent nearly 40 percent of the world's equities trading, the most liquidity of any global exchange group. NYSE Euronext also operates NYSE Liffe, the leading European derivatives business and the world's second-largest derivatives business by value of trading. The company offers comprehensive commercial technology, connectivity and market data products and services through NYSE Technologies.
For more information, please visit: http://www.nyx.com.

Contact Details:

Hans Leufkens
NYSE Euronext
Manager Client Coverage, Listings
Tel +31 20 550 4687
Email h.leufkens@nyx.com

Anne Louise van Lynden van Sandenburg
NYSE Euronext
Business Development, Listings
Tel +31 20 550 4107
Email alvanlynden@nyx.com

Beursplein 5
1012 JW Amsterdam
The Netherlands

Fax: +31 20 550 4966

Loyens & Loeff offers top-level legal and tax advice for international businesses, financial institutions and government bodies.
 
Our Investment Management practice is the largest to offer a full range of investment management services in the Benelux. Our practice is multidisciplinary and closely integrated with other related practice areas, such as Private Equity (focusing specifically on private equity transactions such as leveraged buyouts and venture capital transactions), Tax, Real Estate and Banking & Finance.

Thanks to our closely collaborating legal and tax practices, we have built up a unique and very solid position in the market. With about 1600 employees worldwide, consisting of about 400 tax experts and about the same number of legal experts, we are capable of effectively structuring and supervising both domestic and international matters. We provide services from our six Benelux offices and from our eleven branches based in the world's major financial centres.

Full Contact details:
 
Loyens & Loeff NV
Fred. Roeskestraat 100
1076 ED AMSTERDAM 
 
Tel. +31 20 578 5785
Fax +31 20 578 58 00

Introduction
Lovells is one of the pre-eminent international leading law firms advising on contentious and non-contentious issues in the pharmaceutical, biosciences and medical devices industries. We advise clients on all matters relating to the full pharma / biotech product life cycle, from clinical trial agreements through to off patent strategy and from early stage financing to IPO or M&A consolidation. Life science is a core sector for the firm. Our group of dedicated industry specialists consists of 75 lawyers worldwide, many of whom are scientifically qualified. The team comprises experts in intellectual property, competition, product liability, regulatory, IT and dispute resolution. Lovells combines this expertise with a wide experience in the fields of equity capital markets, M&A and finance offering a full legal service for all our life sciences and venture capital clients.

The Amsterdam office comprises six practice areas:

* Corporate / M&A
Contact partners: Johannes Buntjer, Victor de Vlaam and Jan de Snaijer (civil law notary);

* Intellectual Property / Life Sciences
Contact partners: Klaas Bisschop, Bert Oosting and Marc Wallheimer;

* Banking & Finance, Business Restructuring & Capital Markets
Contact partner: Ken Breken;

* Tax
Contact partner: Anton Louwinger;

* Employment
Contact partner: Anita de Jong;

* Litigation & Arbitration
Contact partner: Klaas Bisschop.

Contact details:
Lovells LLP
Keizersgracht 555, 1017 DR Amsterdam
PO Box 545, 1000 AM Amsterdam
The Netherlands

T: +31 (0)20 55 33 600
F: +31 (0)20 55 33 777
www.lovells.com

www.nautadutilh.com